Less Is More For Melanoma-Fighting Immunotherapy, Nivolumab/Ipilimumab, Study Argues
Published on December 12, 2025 at 04:42PM by Drugs.com - Daily MedNews
FRIDAY, Dec. 12, 2025 — Less might be more when it comes to immunotherapy treatment of melanoma, a new study says. Lower doses of a drug used to treat melanoma can provide better results while reducing side effects, researchers reported Dec...
Read the original article here: https://www.drugs.com/news/less-more-melanoma-fighting-immunotherapy-nivolumab-ipilimumab-study-argues-127933.html